These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 26188809)

  • 1. Needs and availability of snake antivenoms: relevance and application of international guidelines.
    Scheske L; Ruitenberg J; Bissumbhar B
    Int J Health Policy Manag; 2015 Apr; 4(7):447-57. PubMed ID: 26188809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
    Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
    J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving antivenom availability and accessibility: science, technology, and beyond.
    Gutiérrez JM
    Toxicon; 2012 Sep; 60(4):676-87. PubMed ID: 22781134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snakebite envenoming from a global perspective: Towards an integrated approach.
    Gutiérrez JM; Williams D; Fan HW; Warrell DA
    Toxicon; 2010 Dec; 56(7):1223-35. PubMed ID: 19951718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy.
    Keyler DE; Gawarammana I; Gutiérrez JM; Sellahewa KH; McWhorter K; Malleappah R
    Toxicon; 2013 Jul; 69():90-7. PubMed ID: 23454626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries.
    Patikorn C; Ismail AK; Abidin SAZ; Blanco FB; Blessmann J; Choumlivong K; Comandante JD; Doan UV; Mohamed Ismail Z; Khine YY; Maharani T; Nwe MT; Qamruddin RM; Safferi RS; Santamaria E; Tiglao PJG; Trakulsrichai S; Vasaruchapong T; Chaiyakunapruk N; Taychakhoonavudh S; Othman I
    BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35296460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
    Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
    J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snake antivenom product guidelines in India: "the devil is in the details".
    Simpson ID; Norris RL
    Wilderness Environ Med; 2007; 18(3):163-8. PubMed ID: 17896852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of snakebites by the staff of a rural clinic: the impact of providing free antivenom in a nurse-led clinic in Meserani, Tanzania.
    Yates VM; Lebas E; Orpiay R; Bale BJ
    Ann Trop Med Parasitol; 2010 Jul; 104(5):439-48. PubMed ID: 20819312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulnerability to snakebite envenoming: a global mapping of hotspots.
    Longbottom J; Shearer FM; Devine M; Alcoba G; Chappuis F; Weiss DJ; Ray SE; Ray N; Warrell DA; Ruiz de Castañeda R; Williams DJ; Hay SI; Pigott DM
    Lancet; 2018 Aug; 392(10148):673-684. PubMed ID: 30017551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the impact of snakebite envenoming in Latin America and the Caribbean: achievements and challenges ahead.
    Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):530-7. PubMed ID: 25096295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines for the production, control and regulation of snake antivenom immunoglobulins].
    Chippaux JP
    Biol Aujourdhui; 2010; 204(1):87-91. PubMed ID: 20950580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global snakebite crisis--a public health issue misunderstood, not neglected.
    Simpson ID; Norris RL
    Wilderness Environ Med; 2009; 20(1):43-56. PubMed ID: 19364169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Availability of Antivenoms: The Relevance of Public Manufacturing Laboratories.
    Gutiérrez JM
    Toxins (Basel); 2018 Dec; 11(1):. PubMed ID: 30586868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop.
    Gutiérrez JM; Fan HW; Silvera CL; Angulo Y
    Toxicon; 2009 May; 53(6):625-30. PubMed ID: 19673076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspective on the Therapeutics of Anti-Snake Venom.
    Gómez-Betancur I; Gogineni V; Salazar-Ospina A; León F
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31505752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inequalities in access to antivenom: An ethical issue in the management of snakebite envenoming.
    Kallel H; Pujo JM; Houcke S; Resiere D
    Toxicon; 2024 Aug; 247():108030. PubMed ID: 39009044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of a WHO workshop on the standardization and control of antivenoms.
    Theakston RD; Warrell DA; Griffiths E
    Toxicon; 2003 Apr; 41(5):541-57. PubMed ID: 12676433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of snakebite and use of antivenom in Argentina.
    Dolab JA; de Roodt AR; de Titto EH; García SI; Funes R; Salomón OD; Chippaux JP
    Trans R Soc Trop Med Hyg; 2014 May; 108(5):269-76. PubMed ID: 24619585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming.
    Gutiérrez JM; Burnouf T; Harrison RA; Calvete JJ; Kuch U; Warrell DA; Williams DJ;
    Bull World Health Organ; 2014 Jul; 92(7):526-32. PubMed ID: 25110378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.